Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

14.11.2019 | short review

Management of nonmetastatic muscle invasive bladder cancer in the elderly

verfasst von: Prof. Stephan Madersbacher, MD, FEBU

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Summary

A substantial increase in the number of elderly patients with muscle invasive bladder cancer (MIBC) is expected in upcoming years due to demographic changes and the peak incidence of bladder cancer in the 8th decade of life. The management of these patients is mainly driven by chronological age, comorbidities, tumor characteristics (unifocality, multifocality, concomitant carcinoma in situ, depth of invasion) and the presence of tumor-related symptoms (hematuria, pain, bladder dysfunction). A potential algorithm for the treatment of elderly patients with MIBC is presented. Ideally these patients are managed by a multidisciplinary team that includes an in-depth geriatric assessment and in centers experienced with MIBC to avoid any delay for—potentially—curative treatment.
Vorheriger Artikel Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer
Nächster Artikel Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Literatur
1.
2.
Schultzel M, Saltzstein SL, Downs TM, et al. Late age (85 years or older) peak incidence of bladder cancer. J Urol. 2008;179:1302–5.CrossRef
3.
4.
Berger I, Martini T, Wehrberger C, et al. Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75+): a retrospective, multicentre study. Urol Int. 2014;93:296–302.CrossRef
5.
Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112:2384–92.CrossRef
6.
Froehner M, Brausi MA, Herr HW, et al. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol. 2009;56:443–54.CrossRef
7.
Fonteyne V, Ost P, Bellmunt J, et al. Curative treatment for muscle invasive bladder cancer in elderly patients: a systematic review. Eur Urol. 2018;73:40–50.CrossRef
8.
Comploj E, West J, Mian M, et al. Comparison of complications from radical cystectomy between old-old versus oldest-old patients. Urol Int. 2015;94:25–30.CrossRef
9.
Liberman D, Lughezzani G, Sun M, et al. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011;77:660–6.CrossRef
10.
Berger I, Wehrberger C, Ponholzer A, et al. Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older. Urol Int. 2015;94:394–400.CrossRef
11.
Gschwend JE, Hautmann RE, Volkmer BG, et al. Radical cystectomy and urinary diversion in elderly patients with increased comorbidity. Urologe A. 2004;43:930–4.PubMed
12.
Herr HW. Transurethral resection of muscle-invasive bladder cancer:10-year outcome. J Clin Oncol. 2001;19:89–93.CrossRef
13.
Solsona E, Iborra I, Collado A, et al. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol. 2010;184:475–80.CrossRef
14.
Goossens-Laan CA, Leliveld AM, Verhoeven RHA, et al. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. Int J Cancer. 2014;135:905–12.CrossRef
15.
Martini T, Mayr R, Wehrbeger C, et al. Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer. Int Braz J Urol. 2013;39:622–30.CrossRef
16.
Williams SB, Kamat AM, Chamie K et al. Systematic review of comorbidity and competing-risks assessments for bladder cancer patients. Eur Urol Oncol. 2018;1:91–100.CrossRef
17.
Martin C, West JM, Palermo S, et al. Elderly patients undergoing cystectomy, comparing preoperative American Society of Anaesthesiology and Eastern Cooperative Oncology Group score and operative approaches. Urologia. Epub Ahead Print]. 2019
18.
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005 Aug;48(2):202–5; discussion 205–6. Epub 2005 Apr 21.
19.
Leone AR, Zargar-Shoshtari K, Diorio GJ, et al. Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience. Clin Genitourin Cancer. 2017;15:583–9.CrossRef
20.
Noon AP, Albertsen PC, Thomas F, et al. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer. 2013;108:1534–40.CrossRef
Metadaten
Titel
Management of nonmetastatic muscle invasive bladder cancer in the elderly
verfasst von
Prof. Stephan Madersbacher, MD, FEBU
Publikationsdatum
14.11.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-00547-2

Weitere Artikel der Ausgabe 4/2019

Amazing advances in the field of uro-oncology

  • editorial

Targeted therapy in lung cancer—ASCO 2019 update

  • Open Access
  • short review

Giant leiomyoma of the renal capsule: CT and MR imaging features with pathologic correlations

  • case report

Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria

  • Open Access
  • original report

Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract

  • short review

ASCO 2019—Personal highlights on adjuvant breast cancer: (neo-)adjuvant therapy of HER2-negative HR-positive BC

  • short review